nodes	percent_of_prediction	percent_of_DWPC	metapath
Dalfampridine—KCNC3—cerebellar cortex—brain cancer	0.0328	0.0428	CbGeAlD
Dalfampridine—KCNQ4—cochlea—brain cancer	0.0254	0.0331	CbGeAlD
Dalfampridine—KCNQ4—internal ear—brain cancer	0.0241	0.0314	CbGeAlD
Dalfampridine—KCNQ1—cochlea—brain cancer	0.0146	0.019	CbGeAlD
Dalfampridine—KCNC2—ganglion—brain cancer	0.0142	0.0185	CbGeAlD
Dalfampridine—KCNQ1—internal ear—brain cancer	0.0138	0.018	CbGeAlD
Dalfampridine—Balance disorder—Procarbazine—brain cancer	0.0132	0.0566	CcSEcCtD
Dalfampridine—KCNC3—hindbrain—brain cancer	0.009	0.0117	CbGeAlD
Dalfampridine—KCNA2—hindbrain—brain cancer	0.00832	0.0109	CbGeAlD
Dalfampridine—KCND1—hindbrain—brain cancer	0.00796	0.0104	CbGeAlD
Dalfampridine—KCNC1—hindbrain—brain cancer	0.00765	0.00998	CbGeAlD
Dalfampridine—KCNH6—ganglion—brain cancer	0.00719	0.00938	CbGeAlD
Dalfampridine—KCNA6—telencephalon—brain cancer	0.00642	0.00838	CbGeAlD
Dalfampridine—KCNV1—telencephalon—brain cancer	0.00604	0.00788	CbGeAlD
Dalfampridine—KCNC2—telencephalon—brain cancer	0.00546	0.00713	CbGeAlD
Dalfampridine—KCND2—hindbrain—brain cancer	0.0052	0.00679	CbGeAlD
Dalfampridine—KCNC3—brainstem—brain cancer	0.00516	0.00673	CbGeAlD
Dalfampridine—KCNH3—telencephalon—brain cancer	0.00487	0.00635	CbGeAlD
Dalfampridine—KCNA2—brainstem—brain cancer	0.00477	0.00623	CbGeAlD
Dalfampridine—KCNB1—telencephalon—brain cancer	0.00471	0.00615	CbGeAlD
Dalfampridine—KCNG2—cerebellum—brain cancer	0.00471	0.00614	CbGeAlD
Dalfampridine—KCNG4—head—brain cancer	0.0047	0.00614	CbGeAlD
Dalfampridine—KCNB2—head—brain cancer	0.0047	0.00614	CbGeAlD
Dalfampridine—KCNH4—head—brain cancer	0.0047	0.00614	CbGeAlD
Dalfampridine—Infection—Carboplatin—brain cancer	0.00461	0.0197	CcSEcCtD
Dalfampridine—KCND1—brainstem—brain cancer	0.00456	0.00596	CbGeAlD
Dalfampridine—KCNA1—hindbrain—brain cancer	0.00456	0.00595	CbGeAlD
Dalfampridine—KCND3—hindbrain—brain cancer	0.00454	0.00592	CbGeAlD
Dalfampridine—KCNA4—telencephalon—brain cancer	0.00445	0.00581	CbGeAlD
Dalfampridine—KCNA3—telencephalon—brain cancer	0.00445	0.00581	CbGeAlD
Dalfampridine—KCNC2—pituitary gland—brain cancer	0.00445	0.0058	CbGeAlD
Dalfampridine—KCNC1—brainstem—brain cancer	0.00438	0.00572	CbGeAlD
Dalfampridine—KCNH5—head—brain cancer	0.0043	0.00561	CbGeAlD
Dalfampridine—KCNG4—central nervous system—brain cancer	0.00429	0.0056	CbGeAlD
Dalfampridine—KCNH4—central nervous system—brain cancer	0.00429	0.0056	CbGeAlD
Dalfampridine—KCNB2—central nervous system—brain cancer	0.00429	0.0056	CbGeAlD
Dalfampridine—KCNS1—telencephalon—brain cancer	0.00423	0.00553	CbGeAlD
Dalfampridine—KCNA2—telencephalon—brain cancer	0.00423	0.00553	CbGeAlD
Dalfampridine—KCNC4—telencephalon—brain cancer	0.00405	0.00529	CbGeAlD
Dalfampridine—Infection—Lomustine—brain cancer	0.00404	0.0173	CcSEcCtD
Dalfampridine—KCNS2—head—brain cancer	0.004	0.00522	CbGeAlD
Dalfampridine—KCNA6—head—brain cancer	0.004	0.00522	CbGeAlD
Dalfampridine—KCNH3—pituitary gland—brain cancer	0.00396	0.00517	CbGeAlD
Dalfampridine—Chest discomfort—Etoposide—brain cancer	0.00395	0.0169	CcSEcCtD
Dalfampridine—KCNH5—central nervous system—brain cancer	0.00393	0.00512	CbGeAlD
Dalfampridine—KCNC1—telencephalon—brain cancer	0.00389	0.00508	CbGeAlD
Dalfampridine—KCNH8—pituitary gland—brain cancer	0.00384	0.00501	CbGeAlD
Dalfampridine—KCNH3—medulla oblongata—brain cancer	0.00382	0.00499	CbGeAlD
Dalfampridine—KCNG2—brain—brain cancer	0.00382	0.00499	CbGeAlD
Dalfampridine—KCNV1—head—brain cancer	0.00376	0.00491	CbGeAlD
Dalfampridine—KCNH8—medulla oblongata—brain cancer	0.0037	0.00483	CbGeAlD
Dalfampridine—KCNS2—central nervous system—brain cancer	0.00365	0.00476	CbGeAlD
Dalfampridine—KCNA6—central nervous system—brain cancer	0.00365	0.00476	CbGeAlD
Dalfampridine—KCNA4—pituitary gland—brain cancer	0.00362	0.00473	CbGeAlD
Dalfampridine—KCNV2—head—brain cancer	0.00356	0.00465	CbGeAlD
Dalfampridine—KCNA4—medulla oblongata—brain cancer	0.0035	0.00456	CbGeAlD
Dalfampridine—KCNF1—telencephalon—brain cancer	0.00347	0.00453	CbGeAlD
Dalfampridine—KCNS1—pituitary gland—brain cancer	0.00345	0.0045	CbGeAlD
Dalfampridine—KCNH1—endocrine gland—brain cancer	0.00344	0.0045	CbGeAlD
Dalfampridine—KCNV1—central nervous system—brain cancer	0.00343	0.00448	CbGeAlD
Dalfampridine—KCNH3—spinal cord—brain cancer	0.00341	0.00445	CbGeAlD
Dalfampridine—KCNB2—brain—brain cancer	0.00341	0.00445	CbGeAlD
Dalfampridine—KCNG4—brain—brain cancer	0.00341	0.00445	CbGeAlD
Dalfampridine—KCNH4—brain—brain cancer	0.00341	0.00445	CbGeAlD
Dalfampridine—KCNC2—head—brain cancer	0.0034	0.00444	CbGeAlD
Dalfampridine—KCNG3—head—brain cancer	0.0034	0.00444	CbGeAlD
Dalfampridine—KCNH1—head—brain cancer	0.0034	0.00444	CbGeAlD
Dalfampridine—KCNH8—midbrain—brain cancer	0.00339	0.00442	CbGeAlD
Dalfampridine—KCND1—gonad—brain cancer	0.00338	0.00441	CbGeAlD
Dalfampridine—KCNS1—medulla oblongata—brain cancer	0.00333	0.00434	CbGeAlD
Dalfampridine—KCNH8—spinal cord—brain cancer	0.0033	0.00431	CbGeAlD
Dalfampridine—KCNV2—central nervous system—brain cancer	0.00325	0.00425	CbGeAlD
Dalfampridine—KCNA4—midbrain—brain cancer	0.0032	0.00417	CbGeAlD
Dalfampridine—KCNC4—medulla oblongata—brain cancer	0.00318	0.00415	CbGeAlD
Dalfampridine—KCNC1—pituitary gland—brain cancer	0.00317	0.00413	CbGeAlD
Dalfampridine—KCNQ2—brainstem—brain cancer	0.00315	0.00411	CbGeAlD
Dalfampridine—Infestation NOS—Hydroxyurea—brain cancer	0.00313	0.0134	CcSEcCtD
Dalfampridine—Infestation—Hydroxyurea—brain cancer	0.00313	0.0134	CcSEcCtD
Dalfampridine—KCNA3—spinal cord—brain cancer	0.00312	0.00407	CbGeAlD
Dalfampridine—KCNH5—brain—brain cancer	0.00312	0.00407	CbGeAlD
Dalfampridine—KCNG3—central nervous system—brain cancer	0.0031	0.00405	CbGeAlD
Dalfampridine—KCNC2—central nervous system—brain cancer	0.0031	0.00405	CbGeAlD
Dalfampridine—KCNH1—central nervous system—brain cancer	0.0031	0.00405	CbGeAlD
Dalfampridine—KCNA5—telencephalon—brain cancer	0.0031	0.00405	CbGeAlD
Dalfampridine—KCNG1—endocrine gland—brain cancer	0.00307	0.00401	CbGeAlD
Dalfampridine—KCNC1—medulla oblongata—brain cancer	0.00306	0.00399	CbGeAlD
Dalfampridine—KCNS1—midbrain—brain cancer	0.00304	0.00397	CbGeAlD
Dalfampridine—KCNA2—midbrain—brain cancer	0.00304	0.00397	CbGeAlD
Dalfampridine—KCNQ3—telencephalon—brain cancer	0.00304	0.00396	CbGeAlD
Dalfampridine—KCNH1—cerebellum—brain cancer	0.00303	0.00396	CbGeAlD
Dalfampridine—KCNG1—head—brain cancer	0.00303	0.00396	CbGeAlD
Dalfampridine—KCNH3—head—brain cancer	0.00303	0.00396	CbGeAlD
Dalfampridine—KCND2—brainstem—brain cancer	0.00298	0.00389	CbGeAlD
Dalfampridine—KCNB1—endocrine gland—brain cancer	0.00297	0.00388	CbGeAlD
Dalfampridine—KCNA2—spinal cord—brain cancer	0.00297	0.00387	CbGeAlD
Dalfampridine—Tremor—Procarbazine—brain cancer	0.00296	0.0127	CcSEcCtD
Dalfampridine—KCNH8—head—brain cancer	0.00294	0.00383	CbGeAlD
Dalfampridine—KCNB1—head—brain cancer	0.00294	0.00383	CbGeAlD
Dalfampridine—KCNC4—midbrain—brain cancer	0.00291	0.0038	CbGeAlD
Dalfampridine—KCNS2—brain—brain cancer	0.0029	0.00378	CbGeAlD
Dalfampridine—KCNA6—brain—brain cancer	0.0029	0.00378	CbGeAlD
Dalfampridine—KCNC3—head—brain cancer	0.00285	0.00372	CbGeAlD
Dalfampridine—KCNF1—pituitary gland—brain cancer	0.00282	0.00369	CbGeAlD
Dalfampridine—KCNQ2—telencephalon—brain cancer	0.0028	0.00365	CbGeAlD
Dalfampridine—KCNC1—midbrain—brain cancer	0.00279	0.00365	CbGeAlD
Dalfampridine—KCNH6—telencephalon—brain cancer	0.00277	0.00362	CbGeAlD
Dalfampridine—KCNA4—head—brain cancer	0.00277	0.00362	CbGeAlD
Dalfampridine—KCNA3—head—brain cancer	0.00277	0.00362	CbGeAlD
Dalfampridine—KCNG1—central nervous system—brain cancer	0.00277	0.00361	CbGeAlD
Dalfampridine—KCNH3—central nervous system—brain cancer	0.00277	0.00361	CbGeAlD
Dalfampridine—Convulsion—Procarbazine—brain cancer	0.00274	0.0117	CcSEcCtD
Dalfampridine—KCNC1—spinal cord—brain cancer	0.00273	0.00356	CbGeAlD
Dalfampridine—KCNF1—medulla oblongata—brain cancer	0.00272	0.00356	CbGeAlD
Dalfampridine—KCNV1—brain—brain cancer	0.00272	0.00356	CbGeAlD
Dalfampridine—KCNQ5—midbrain—brain cancer	0.00272	0.00355	CbGeAlD
Dalfampridine—KCNG1—cerebellum—brain cancer	0.0027	0.00353	CbGeAlD
Dalfampridine—KCNH3—cerebellum—brain cancer	0.0027	0.00353	CbGeAlD
Dalfampridine—Anxiety—Procarbazine—brain cancer	0.00268	0.0115	CcSEcCtD
Dalfampridine—KCNB1—central nervous system—brain cancer	0.00268	0.0035	CbGeAlD
Dalfampridine—KCNH8—central nervous system—brain cancer	0.00268	0.0035	CbGeAlD
Dalfampridine—KCNA2—endocrine gland—brain cancer	0.00267	0.00349	CbGeAlD
Dalfampridine—KCND2—telencephalon—brain cancer	0.00265	0.00345	CbGeAlD
Dalfampridine—KCNA2—head—brain cancer	0.00264	0.00344	CbGeAlD
Dalfampridine—KCNS1—head—brain cancer	0.00264	0.00344	CbGeAlD
Dalfampridine—KCNH8—cerebellum—brain cancer	0.00262	0.00342	CbGeAlD
Dalfampridine—KCNA1—brainstem—brain cancer	0.00261	0.00341	CbGeAlD
Dalfampridine—KCNC3—central nervous system—brain cancer	0.0026	0.00339	CbGeAlD
Dalfampridine—KCND3—brainstem—brain cancer	0.0026	0.00339	CbGeAlD
Dalfampridine—Confusional state—Procarbazine—brain cancer	0.0026	0.0111	CcSEcCtD
Dalfampridine—KCNA5—gonad—brain cancer	0.00259	0.00338	CbGeAlD
Dalfampridine—KCNV2—brain—brain cancer	0.00258	0.00337	CbGeAlD
Dalfampridine—Vomiting—Lomustine—brain cancer	0.00258	0.0111	CcSEcCtD
Dalfampridine—Infection—Procarbazine—brain cancer	0.00256	0.011	CcSEcCtD
Dalfampridine—KCND1—endocrine gland—brain cancer	0.00255	0.00333	CbGeAlD
Dalfampridine—Angiopathy—Hydroxyurea—brain cancer	0.00255	0.0109	CcSEcCtD
Dalfampridine—KCNC3—cerebellum—brain cancer	0.00254	0.00332	CbGeAlD
Dalfampridine—KCNA4—central nervous system—brain cancer	0.00253	0.0033	CbGeAlD
Dalfampridine—KCNA3—central nervous system—brain cancer	0.00253	0.0033	CbGeAlD
Dalfampridine—KCNA5—pituitary gland—brain cancer	0.00253	0.0033	CbGeAlD
Dalfampridine—KCND1—head—brain cancer	0.00252	0.00329	CbGeAlD
Dalfampridine—KCNC4—head—brain cancer	0.00252	0.00329	CbGeAlD
Dalfampridine—KCNF1—midbrain—brain cancer	0.00249	0.00325	CbGeAlD
Dalfampridine—KCNS3—pituitary gland—brain cancer	0.00247	0.00323	CbGeAlD
Dalfampridine—KCNA4—cerebellum—brain cancer	0.00247	0.00323	CbGeAlD
Dalfampridine—KCNA3—cerebellum—brain cancer	0.00247	0.00323	CbGeAlD
Dalfampridine—KCNH1—brain—brain cancer	0.00246	0.00322	CbGeAlD
Dalfampridine—KCNG3—brain—brain cancer	0.00246	0.00322	CbGeAlD
Dalfampridine—KCNC2—brain—brain cancer	0.00246	0.00322	CbGeAlD
Dalfampridine—Urinary tract infection—Carmustine—brain cancer	0.00246	0.0105	CcSEcCtD
Dalfampridine—Infestation—Temozolomide—brain cancer	0.00244	0.0105	CcSEcCtD
Dalfampridine—Infestation NOS—Temozolomide—brain cancer	0.00244	0.0105	CcSEcCtD
Dalfampridine—KCNA5—medulla oblongata—brain cancer	0.00244	0.00318	CbGeAlD
Dalfampridine—KCNF1—spinal cord—brain cancer	0.00243	0.00317	CbGeAlD
Dalfampridine—KCNC1—head—brain cancer	0.00242	0.00316	CbGeAlD
Dalfampridine—KCNH7—head—brain cancer	0.00242	0.00316	CbGeAlD
Dalfampridine—KCNQ4—head—brain cancer	0.00242	0.00316	CbGeAlD
Dalfampridine—Nausea—Lomustine—brain cancer	0.00241	0.0103	CcSEcCtD
Dalfampridine—Hypotension—Procarbazine—brain cancer	0.00241	0.0103	CcSEcCtD
Dalfampridine—KCNS1—central nervous system—brain cancer	0.00241	0.00314	CbGeAlD
Dalfampridine—KCNA2—central nervous system—brain cancer	0.00241	0.00314	CbGeAlD
Dalfampridine—KCNS3—medulla oblongata—brain cancer	0.00239	0.00311	CbGeAlD
Dalfampridine—KCNQ3—medulla oblongata—brain cancer	0.00239	0.00311	CbGeAlD
Dalfampridine—Urinary tract infection—Temozolomide—brain cancer	0.00238	0.0102	CcSEcCtD
Dalfampridine—KCNQ5—head—brain cancer	0.00236	0.00308	CbGeAlD
Dalfampridine—KCNA2—cerebellum—brain cancer	0.00235	0.00307	CbGeAlD
Dalfampridine—KCNQ2—gonad—brain cancer	0.00233	0.00304	CbGeAlD
Dalfampridine—Insomnia—Procarbazine—brain cancer	0.00233	0.00998	CcSEcCtD
Dalfampridine—KCNA1—telencephalon—brain cancer	0.00232	0.00303	CbGeAlD
Dalfampridine—Paraesthesia—Procarbazine—brain cancer	0.00232	0.00991	CcSEcCtD
Dalfampridine—KCND3—telencephalon—brain cancer	0.00231	0.00301	CbGeAlD
Dalfampridine—KCND1—central nervous system—brain cancer	0.0023	0.003	CbGeAlD
Dalfampridine—KCNC4—central nervous system—brain cancer	0.0023	0.003	CbGeAlD
Dalfampridine—KCNQ2—pituitary gland—brain cancer	0.00228	0.00297	CbGeAlD
Dalfampridine—KCND1—cerebellum—brain cancer	0.00225	0.00294	CbGeAlD
Dalfampridine—KCNC4—cerebellum—brain cancer	0.00225	0.00294	CbGeAlD
Dalfampridine—Connective tissue disorder—Carmustine—brain cancer	0.00223	0.00955	CcSEcCtD
Dalfampridine—KCNH7—central nervous system—brain cancer	0.00221	0.00289	CbGeAlD
Dalfampridine—KCNC1—central nervous system—brain cancer	0.00221	0.00289	CbGeAlD
Dalfampridine—Constipation—Procarbazine—brain cancer	0.00221	0.00944	CcSEcCtD
Dalfampridine—KCNH3—brain—brain cancer	0.0022	0.00287	CbGeAlD
Dalfampridine—KCNG1—brain—brain cancer	0.0022	0.00287	CbGeAlD
Dalfampridine—KCNF1—endocrine gland—brain cancer	0.00219	0.00285	CbGeAlD
Dalfampridine—KCNS3—midbrain—brain cancer	0.00218	0.00285	CbGeAlD
Dalfampridine—KCNQ3—midbrain—brain cancer	0.00218	0.00285	CbGeAlD
Dalfampridine—KCNA5—spinal cord—brain cancer	0.00217	0.00284	CbGeAlD
Dalfampridine—KCNH7—cerebellum—brain cancer	0.00216	0.00282	CbGeAlD
Dalfampridine—KCNC1—cerebellum—brain cancer	0.00216	0.00282	CbGeAlD
Dalfampridine—KCNQ4—cerebellum—brain cancer	0.00216	0.00282	CbGeAlD
Dalfampridine—KCNF1—head—brain cancer	0.00216	0.00282	CbGeAlD
Dalfampridine—Connective tissue disorder—Temozolomide—brain cancer	0.00216	0.00923	CcSEcCtD
Dalfampridine—KCND2—pituitary gland—brain cancer	0.00216	0.00281	CbGeAlD
Dalfampridine—KCNQ5—central nervous system—brain cancer	0.00215	0.00281	CbGeAlD
Dalfampridine—KCNS3—spinal cord—brain cancer	0.00213	0.00278	CbGeAlD
Dalfampridine—KCNH8—brain—brain cancer	0.00213	0.00278	CbGeAlD
Dalfampridine—KCNB1—brain—brain cancer	0.00213	0.00278	CbGeAlD
Dalfampridine—Feeling abnormal—Procarbazine—brain cancer	0.00213	0.00909	CcSEcCtD
Dalfampridine—Convulsion—Hydroxyurea—brain cancer	0.00212	0.00907	CcSEcCtD
Dalfampridine—KCND2—medulla oblongata—brain cancer	0.00208	0.00271	CbGeAlD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00207	0.00885	CcSEcCtD
Dalfampridine—KCNC3—brain—brain cancer	0.00206	0.00269	CbGeAlD
Dalfampridine—Urticaria—Procarbazine—brain cancer	0.00205	0.00877	CcSEcCtD
Dalfampridine—KCNA3—brain—brain cancer	0.00201	0.00262	CbGeAlD
Dalfampridine—KCNA4—brain—brain cancer	0.00201	0.00262	CbGeAlD
Dalfampridine—Angiopathy—Temozolomide—brain cancer	0.00199	0.00852	CcSEcCtD
Dalfampridine—Mental disorder—Carmustine—brain cancer	0.00199	0.00851	CcSEcCtD
Dalfampridine—Infection—Hydroxyurea—brain cancer	0.00198	0.00848	CcSEcCtD
Dalfampridine—Immune system disorder—Temozolomide—brain cancer	0.00198	0.00848	CcSEcCtD
Dalfampridine—Mediastinal disorder—Temozolomide—brain cancer	0.00198	0.00846	CcSEcCtD
Dalfampridine—KCNF1—central nervous system—brain cancer	0.00197	0.00257	CbGeAlD
Dalfampridine—Nervous system disorder—Hydroxyurea—brain cancer	0.00196	0.00837	CcSEcCtD
Dalfampridine—KCNA5—endocrine gland—brain cancer	0.00196	0.00255	CbGeAlD
Dalfampridine—Infestation—Etoposide—brain cancer	0.00196	0.00837	CcSEcCtD
Dalfampridine—Infestation NOS—Etoposide—brain cancer	0.00196	0.00837	CcSEcCtD
Dalfampridine—Skin disorder—Hydroxyurea—brain cancer	0.00194	0.00829	CcSEcCtD
Dalfampridine—KCNA5—head—brain cancer	0.00193	0.00252	CbGeAlD
Dalfampridine—KCNF1—cerebellum—brain cancer	0.00193	0.00251	CbGeAlD
Dalfampridine—Mental disorder—Temozolomide—brain cancer	0.00192	0.00823	CcSEcCtD
Dalfampridine—Back pain—Carmustine—brain cancer	0.00191	0.00818	CcSEcCtD
Dalfampridine—KCNA2—brain—brain cancer	0.00191	0.00249	CbGeAlD
Dalfampridine—KCNS1—brain—brain cancer	0.00191	0.00249	CbGeAlD
Dalfampridine—KCND2—midbrain—brain cancer	0.0019	0.00248	CbGeAlD
Dalfampridine—Hypersensitivity—Procarbazine—brain cancer	0.0019	0.00813	CcSEcCtD
Dalfampridine—KCNS3—head—brain cancer	0.00189	0.00247	CbGeAlD
Dalfampridine—KCNQ3—head—brain cancer	0.00189	0.00247	CbGeAlD
Dalfampridine—KCND2—spinal cord—brain cancer	0.00185	0.00242	CbGeAlD
Dalfampridine—Tremor—Carmustine—brain cancer	0.00185	0.00792	CcSEcCtD
Dalfampridine—Asthenia—Procarbazine—brain cancer	0.00185	0.00792	CcSEcCtD
Dalfampridine—Back pain—Temozolomide—brain cancer	0.00185	0.00791	CcSEcCtD
Dalfampridine—KCND1—brain—brain cancer	0.00183	0.00239	CbGeAlD
Dalfampridine—KCNC4—brain—brain cancer	0.00183	0.00239	CbGeAlD
Dalfampridine—KCNQ1—pituitary gland—brain cancer	0.00182	0.00237	CbGeAlD
Dalfampridine—Tremor—Temozolomide—brain cancer	0.00179	0.00766	CcSEcCtD
Dalfampridine—Dyspnoea—Hydroxyurea—brain cancer	0.00178	0.00761	CcSEcCtD
Dalfampridine—KCNA5—central nervous system—brain cancer	0.00176	0.0023	CbGeAlD
Dalfampridine—KCNQ2—endocrine gland—brain cancer	0.00176	0.0023	CbGeAlD
Dalfampridine—Dyspepsia—Hydroxyurea—brain cancer	0.00176	0.00752	CcSEcCtD
Dalfampridine—KCNQ1—medulla oblongata—brain cancer	0.00176	0.00229	CbGeAlD
Dalfampridine—KCNH7—brain—brain cancer	0.00176	0.00229	CbGeAlD
Dalfampridine—KCNC1—brain—brain cancer	0.00176	0.00229	CbGeAlD
Dalfampridine—KCNQ4—brain—brain cancer	0.00176	0.00229	CbGeAlD
Dalfampridine—Angioedema—Temozolomide—brain cancer	0.00175	0.00747	CcSEcCtD
Dalfampridine—KCNQ2—head—brain cancer	0.00174	0.00227	CbGeAlD
Dalfampridine—KCNQ3—central nervous system—brain cancer	0.00173	0.00225	CbGeAlD
Dalfampridine—KCNH6—head—brain cancer	0.00173	0.00225	CbGeAlD
Dalfampridine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00172	0.00737	CcSEcCtD
Dalfampridine—Convulsion—Carmustine—brain cancer	0.00171	0.00733	CcSEcCtD
Dalfampridine—KCNQ5—brain—brain cancer	0.00171	0.00223	CbGeAlD
Dalfampridine—Constipation—Hydroxyurea—brain cancer	0.00171	0.0073	CcSEcCtD
Dalfampridine—Dizziness—Procarbazine—brain cancer	0.00171	0.0073	CcSEcCtD
Dalfampridine—KCNQ3—cerebellum—brain cancer	0.00169	0.0022	CbGeAlD
Dalfampridine—Chest pain—Carmustine—brain cancer	0.00168	0.0072	CcSEcCtD
Dalfampridine—Anxiety—Carmustine—brain cancer	0.00168	0.00718	CcSEcCtD
Dalfampridine—KCNA1—midbrain—brain cancer	0.00167	0.00217	CbGeAlD
Dalfampridine—KCND3—midbrain—brain cancer	0.00166	0.00216	CbGeAlD
Dalfampridine—Convulsion—Temozolomide—brain cancer	0.00166	0.00708	CcSEcCtD
Dalfampridine—KCND2—head—brain cancer	0.00165	0.00215	CbGeAlD
Dalfampridine—Feeling abnormal—Hydroxyurea—brain cancer	0.00164	0.00704	CcSEcCtD
Dalfampridine—Vomiting—Procarbazine—brain cancer	0.00164	0.00702	CcSEcCtD
Dalfampridine—Confusional state—Carmustine—brain cancer	0.00163	0.00696	CcSEcCtD
Dalfampridine—Rash—Procarbazine—brain cancer	0.00163	0.00696	CcSEcCtD
Dalfampridine—KCNA1—spinal cord—brain cancer	0.00163	0.00212	CbGeAlD
Dalfampridine—Dermatitis—Procarbazine—brain cancer	0.00162	0.00695	CcSEcCtD
Dalfampridine—Anxiety—Temozolomide—brain cancer	0.00162	0.00694	CcSEcCtD
Dalfampridine—Headache—Procarbazine—brain cancer	0.00162	0.00691	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00162	0.00691	CcSEcCtD
Dalfampridine—Infection—Carmustine—brain cancer	0.0016	0.00686	CcSEcCtD
Dalfampridine—Angiopathy—Etoposide—brain cancer	0.00159	0.00682	CcSEcCtD
Dalfampridine—KCNQ2—central nervous system—brain cancer	0.00159	0.00207	CbGeAlD
Dalfampridine—Immune system disorder—Etoposide—brain cancer	0.00159	0.00679	CcSEcCtD
Dalfampridine—Mediastinal disorder—Etoposide—brain cancer	0.00158	0.00677	CcSEcCtD
Dalfampridine—KCNH6—central nervous system—brain cancer	0.00158	0.00206	CbGeAlD
Dalfampridine—Confusional state—Temozolomide—brain cancer	0.00157	0.00673	CcSEcCtD
Dalfampridine—KCNF1—brain—brain cancer	0.00156	0.00204	CbGeAlD
Dalfampridine—Anaphylactic shock—Temozolomide—brain cancer	0.00156	0.00667	CcSEcCtD
Dalfampridine—KCNQ2—cerebellum—brain cancer	0.00155	0.00203	CbGeAlD
Dalfampridine—Infection—Temozolomide—brain cancer	0.00155	0.00663	CcSEcCtD
Dalfampridine—Nausea—Procarbazine—brain cancer	0.00153	0.00655	CcSEcCtD
Dalfampridine—Nervous system disorder—Temozolomide—brain cancer	0.00153	0.00654	CcSEcCtD
Dalfampridine—Skin disorder—Temozolomide—brain cancer	0.00151	0.00648	CcSEcCtD
Dalfampridine—Hypotension—Carmustine—brain cancer	0.00151	0.00645	CcSEcCtD
Dalfampridine—KCND2—central nervous system—brain cancer	0.0015	0.00196	CbGeAlD
Dalfampridine—Back pain—Etoposide—brain cancer	0.00148	0.00633	CcSEcCtD
Dalfampridine—KCND2—cerebellum—brain cancer	0.00147	0.00192	CbGeAlD
Dalfampridine—Hypersensitivity—Hydroxyurea—brain cancer	0.00147	0.00629	CcSEcCtD
Dalfampridine—Insomnia—Carmustine—brain cancer	0.00146	0.00624	CcSEcCtD
Dalfampridine—Paraesthesia—Carmustine—brain cancer	0.00145	0.0062	CcSEcCtD
Dalfampridine—KCNA1—head—brain cancer	0.00144	0.00189	CbGeAlD
Dalfampridine—Dyspnoea—Carmustine—brain cancer	0.00144	0.00615	CcSEcCtD
Dalfampridine—KCND3—head—brain cancer	0.00144	0.00188	CbGeAlD
Dalfampridine—Asthenia—Hydroxyurea—brain cancer	0.00143	0.00613	CcSEcCtD
Dalfampridine—Insomnia—Temozolomide—brain cancer	0.00141	0.00603	CcSEcCtD
Dalfampridine—KCNQ1—endocrine gland—brain cancer	0.00141	0.00184	CbGeAlD
Dalfampridine—Paraesthesia—Temozolomide—brain cancer	0.0014	0.00599	CcSEcCtD
Dalfampridine—KCNA5—brain—brain cancer	0.0014	0.00183	CbGeAlD
Dalfampridine—Gastrointestinal disorder—Carmustine—brain cancer	0.00139	0.00596	CcSEcCtD
Dalfampridine—KCNQ1—head—brain cancer	0.00139	0.00182	CbGeAlD
Dalfampridine—Dyspnoea—Temozolomide—brain cancer	0.00139	0.00595	CcSEcCtD
Dalfampridine—Constipation—Carmustine—brain cancer	0.00138	0.0059	CcSEcCtD
Dalfampridine—Dyspepsia—Temozolomide—brain cancer	0.00137	0.00587	CcSEcCtD
Dalfampridine—KCNS3—brain—brain cancer	0.00137	0.00179	CbGeAlD
Dalfampridine—KCNQ3—brain—brain cancer	0.00137	0.00179	CbGeAlD
Dalfampridine—Gastrointestinal disorder—Temozolomide—brain cancer	0.00135	0.00576	CcSEcCtD
Dalfampridine—Constipation—Temozolomide—brain cancer	0.00133	0.0057	CcSEcCtD
Dalfampridine—Feeling abnormal—Carmustine—brain cancer	0.00133	0.00569	CcSEcCtD
Dalfampridine—Convulsion—Etoposide—brain cancer	0.00132	0.00567	CcSEcCtD
Dalfampridine—Dizziness—Hydroxyurea—brain cancer	0.00132	0.00565	CcSEcCtD
Dalfampridine—KCNA1—central nervous system—brain cancer	0.00132	0.00172	CbGeAlD
Dalfampridine—KCND3—central nervous system—brain cancer	0.00131	0.00171	CbGeAlD
Dalfampridine—Chest pain—Etoposide—brain cancer	0.0013	0.00557	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.00129	0.00553	CcSEcCtD
Dalfampridine—KCNA1—cerebellum—brain cancer	0.00129	0.00168	CbGeAlD
Dalfampridine—Feeling abnormal—Temozolomide—brain cancer	0.00128	0.0055	CcSEcCtD
Dalfampridine—KCND3—cerebellum—brain cancer	0.00128	0.00167	CbGeAlD
Dalfampridine—Vomiting—Hydroxyurea—brain cancer	0.00127	0.00543	CcSEcCtD
Dalfampridine—KCNQ2—brain—brain cancer	0.00126	0.00165	CbGeAlD
Dalfampridine—Rash—Hydroxyurea—brain cancer	0.00126	0.00538	CcSEcCtD
Dalfampridine—Confusional state—Etoposide—brain cancer	0.00126	0.00538	CcSEcCtD
Dalfampridine—Dermatitis—Hydroxyurea—brain cancer	0.00126	0.00538	CcSEcCtD
Dalfampridine—KCNH6—brain—brain cancer	0.00125	0.00163	CbGeAlD
Dalfampridine—Headache—Hydroxyurea—brain cancer	0.00125	0.00535	CcSEcCtD
Dalfampridine—Anaphylactic shock—Etoposide—brain cancer	0.00125	0.00534	CcSEcCtD
Dalfampridine—Infection—Etoposide—brain cancer	0.00124	0.0053	CcSEcCtD
Dalfampridine—Urticaria—Temozolomide—brain cancer	0.00124	0.0053	CcSEcCtD
Dalfampridine—Skin disorder—Etoposide—brain cancer	0.00121	0.00519	CcSEcCtD
Dalfampridine—KCND2—brain—brain cancer	0.00119	0.00156	CbGeAlD
Dalfampridine—Hypersensitivity—Carmustine—brain cancer	0.00119	0.00509	CcSEcCtD
Dalfampridine—Nausea—Hydroxyurea—brain cancer	0.00119	0.00507	CcSEcCtD
Dalfampridine—Hypotension—Etoposide—brain cancer	0.00117	0.00499	CcSEcCtD
Dalfampridine—Asthenia—Carmustine—brain cancer	0.00116	0.00495	CcSEcCtD
Dalfampridine—Hypersensitivity—Temozolomide—brain cancer	0.00115	0.00492	CcSEcCtD
Dalfampridine—Paraesthesia—Etoposide—brain cancer	0.00112	0.00479	CcSEcCtD
Dalfampridine—Asthenia—Temozolomide—brain cancer	0.00112	0.00479	CcSEcCtD
Dalfampridine—Dyspnoea—Etoposide—brain cancer	0.00111	0.00476	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Etoposide—brain cancer	0.00108	0.00461	CcSEcCtD
Dalfampridine—Dizziness—Carmustine—brain cancer	0.00107	0.00457	CcSEcCtD
Dalfampridine—Constipation—Etoposide—brain cancer	0.00107	0.00457	CcSEcCtD
Dalfampridine—KCNA1—brain—brain cancer	0.00105	0.00137	CbGeAlD
Dalfampridine—KCND3—brain—brain cancer	0.00104	0.00136	CbGeAlD
Dalfampridine—Dizziness—Temozolomide—brain cancer	0.00103	0.00441	CcSEcCtD
Dalfampridine—Feeling abnormal—Etoposide—brain cancer	0.00103	0.0044	CcSEcCtD
Dalfampridine—Vomiting—Carmustine—brain cancer	0.00103	0.00439	CcSEcCtD
Dalfampridine—Rash—Carmustine—brain cancer	0.00102	0.00435	CcSEcCtD
Dalfampridine—Dermatitis—Carmustine—brain cancer	0.00102	0.00435	CcSEcCtD
Dalfampridine—Headache—Carmustine—brain cancer	0.00101	0.00432	CcSEcCtD
Dalfampridine—KCNQ1—brain—brain cancer	0.00101	0.00132	CbGeAlD
Dalfampridine—Vomiting—Temozolomide—brain cancer	0.000991	0.00424	CcSEcCtD
Dalfampridine—Urticaria—Etoposide—brain cancer	0.000991	0.00424	CcSEcCtD
Dalfampridine—Rash—Temozolomide—brain cancer	0.000983	0.00421	CcSEcCtD
Dalfampridine—Dermatitis—Temozolomide—brain cancer	0.000982	0.0042	CcSEcCtD
Dalfampridine—Headache—Temozolomide—brain cancer	0.000977	0.00418	CcSEcCtD
Dalfampridine—Nausea—Carmustine—brain cancer	0.000958	0.0041	CcSEcCtD
Dalfampridine—Nausea—Temozolomide—brain cancer	0.000926	0.00396	CcSEcCtD
Dalfampridine—Hypersensitivity—Etoposide—brain cancer	0.000919	0.00393	CcSEcCtD
Dalfampridine—Asthenia—Etoposide—brain cancer	0.000895	0.00383	CcSEcCtD
Dalfampridine—KCNH2—telencephalon—brain cancer	0.000852	0.00111	CbGeAlD
Dalfampridine—Dizziness—Etoposide—brain cancer	0.000825	0.00353	CcSEcCtD
Dalfampridine—Vomiting—Etoposide—brain cancer	0.000793	0.00339	CcSEcCtD
Dalfampridine—Rash—Etoposide—brain cancer	0.000787	0.00337	CcSEcCtD
Dalfampridine—Dermatitis—Etoposide—brain cancer	0.000786	0.00336	CcSEcCtD
Dalfampridine—Headache—Etoposide—brain cancer	0.000782	0.00334	CcSEcCtD
Dalfampridine—Nausea—Etoposide—brain cancer	0.000741	0.00317	CcSEcCtD
Dalfampridine—KCNH2—pituitary gland—brain cancer	0.000694	0.000905	CbGeAlD
Dalfampridine—KCNH2—medulla oblongata—brain cancer	0.000669	0.000874	CbGeAlD
Dalfampridine—CYP2E1—telencephalon—brain cancer	0.000656	0.000856	CbGeAlD
Dalfampridine—KCNH2—midbrain—brain cancer	0.000612	0.000798	CbGeAlD
Dalfampridine—KCNH2—spinal cord—brain cancer	0.000597	0.000779	CbGeAlD
Dalfampridine—KCNH2—endocrine gland—brain cancer	0.000537	0.000701	CbGeAlD
Dalfampridine—KCNH2—head—brain cancer	0.000531	0.000692	CbGeAlD
Dalfampridine—CYP2E1—medulla oblongata—brain cancer	0.000516	0.000673	CbGeAlD
Dalfampridine—KCNH2—central nervous system—brain cancer	0.000484	0.000632	CbGeAlD
Dalfampridine—KCNH2—cerebellum—brain cancer	0.000473	0.000618	CbGeAlD
Dalfampridine—CYP2E1—spinal cord—brain cancer	0.00046	0.0006	CbGeAlD
Dalfampridine—CYP2E1—endocrine gland—brain cancer	0.000414	0.00054	CbGeAlD
Dalfampridine—CYP2E1—head—brain cancer	0.000409	0.000533	CbGeAlD
Dalfampridine—KCNH2—brain—brain cancer	0.000384	0.000502	CbGeAlD
Dalfampridine—CYP2E1—central nervous system—brain cancer	0.000373	0.000487	CbGeAlD
Dalfampridine—CYP2E1—cerebellum—brain cancer	0.000365	0.000476	CbGeAlD
Dalfampridine—CYP2E1—brain—brain cancer	0.000296	0.000386	CbGeAlD
